Insights

Recent Marketing Initiatives Phathom Pharmaceuticals has been actively launching broadcast ad campaigns and direct-to-consumer marketing initiatives for their flagship product, Voquezna, to raise awareness and engage with potential customers.

Innovative Telehealth Feature The introduction of a telehealth feature alongside the acid blocker marketing campaign showcases Phathom's commitment to leveraging technology to connect with consumers remotely, presenting a promising avenue for sales expansion.

Broad Commercial Availability The wide commercial availability of Voquezna, with distribution through platforms like Express Scripts, indicates a strong market presence and accessibility, which can facilitate sales growth and market penetration.

NDA Submission for Non-Erosive GERD Phathom's recent NDA submission for Non-Erosive GERD treatment signifies a strategic expansion of their product portfolio and potentially opens up new market segments for sales team to explore and target.

Strong Financial Backing With a revenue range of $10M - 50M and significant funding of $130M, Phathom Pharmaceuticals demonstrates financial stability and the capacity to support sales strategies for sustained growth and market competitiveness.

Phathom Pharmaceuticals Tech Stack

Phathom Pharmaceuticals uses 8 technology products and services including SiteCatalyst, Adobe Photoshop, Drupal, and more. Explore Phathom Pharmaceuticals's tech stack below.

  • SiteCatalyst
    Analytics
  • Adobe Photoshop
    Cad & Graphics
  • Drupal
    Content Management System
  • Microsoft PowerPoint
    Editors
  • Exhibit
    Javascript Graphics
  • Google Tag Manager
    Tag Management
  • Acquia Cloud Site Factory
    Web Hosting
  • TablePress
    Web Platform Extensions

Media & News

Phathom Pharmaceuticals's Email Address Formats

Phathom Pharmaceuticals uses at least 1 format(s):
Phathom Pharmaceuticals Email FormatsExamplePercentage
FLast@phathompharma.comJDoe@phathompharma.com
89%
FirstLast@phathompharma.comJohnDoe@phathompharma.com
8%
FL@phathompharma.comJD@phathompharma.com
2%
Last@phathompharma.comDoe@phathompharma.com
1%

Frequently Asked Questions

Where is Phathom Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Phathom Pharmaceuticals's main headquarters is located at 100 Campus Drive Suite 102 Florham Park, New Jersey 07932 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Phathom Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Phathom Pharmaceuticals is a publicly traded company; the company's stock symbol is PHAT.

What is Phathom Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Phathom Pharmaceuticals's official website is phathompharma.com and has social profiles on LinkedIn.

How much revenue does Phathom Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of December 2024, Phathom Pharmaceuticals's annual revenue reached $35M.

What is Phathom Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Phathom Pharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Phathom Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of December 2024, Phathom Pharmaceuticals has approximately 394 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief People Officer: P. C.Chief Commercial Officer: M. G.Chief Medical Officer: E. L.. Explore Phathom Pharmaceuticals's employee directory with LeadIQ.

What industry does Phathom Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Phathom Pharmaceuticals operates in the Biotechnology Research industry.

What technology does Phathom Pharmaceuticals use?

Minus sign iconPlus sign icon
Phathom Pharmaceuticals's tech stack includes SiteCatalystAdobe PhotoshopDrupalMicrosoft PowerPointExhibitGoogle Tag ManagerAcquia Cloud Site FactoryTablePress.

What is Phathom Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Phathom Pharmaceuticals's email format typically follows the pattern of . Find more Phathom Pharmaceuticals email formats with LeadIQ.

How much funding has Phathom Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of December 2024, Phathom Pharmaceuticals has raised $130M in funding. The last funding round occurred on Aug 19, 2024 for $130M.

When was Phathom Pharmaceuticals founded?

Minus sign iconPlus sign icon
Phathom Pharmaceuticals was founded in 2018.
Phathom Pharmaceuticals

Phathom Pharmaceuticals

Biotechnology ResearchNew Jersey, United States201-500 Employees

Phathom Pharmaceuticals (Nasdaq: PHAT) is a biopharmaceutical company committed to transforming the treatment landscape for people suffering from gastrointestinal (GI) diseases related to acid. 

We are a team of highly driven pharmaceutical professionals who are passionate about our mission to address unmet needs for patients and improve their quality of life. By ensuring all voices are heard, holding ourselves accountable to be equitable and just, and authentically supporting the people and communities impacted by our work, we strive to create a sense of inclusion and belonging.

We are looking for self-motivated, creative problem solvers who are excited by the idea of working in a fast-paced start-up environment and contributing to our growth.

Section iconCompany Overview

Headquarters
100 Campus Drive Suite 102 Florham Park, New Jersey 07932 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PHAT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
201-500

Section iconFunding & Financials

  • $130M

    Phathom Pharmaceuticals has raised a total of $130M of funding over 6 rounds. Their latest funding round was raised on Aug 19, 2024 in the amount of $130M.

  • $10M$50M

    Phathom Pharmaceuticals's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $130M

    Phathom Pharmaceuticals has raised a total of $130M of funding over 6 rounds. Their latest funding round was raised on Aug 19, 2024 in the amount of $130M.

  • $10M$50M

    Phathom Pharmaceuticals's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.